{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:18:57Z","timestamp":1790205537185,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1124\/dmd.107.017806","type":"journal-article","created":{"date-parts":[[2007,9,26]],"date-time":"2007-09-26T20:58:56Z","timestamp":1190840336000},"page":"2270-2280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Characterization of the UDP Glucuronosyltransferase Activity of Human Liver Microsomes Genotyped for the UGT1A1*28 Polymorphism"],"prefix":"10.1016","volume":"35","author":[{"given":"Donglu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duxi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Gambardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Rahematpura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Donegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Griffith","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.107.017806_bib1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/dmd.31.7.815","article-title":"The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective","volume":"31","author":"Bjornsson","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.017806_bib2","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1056\/NEJM199511023331802","article-title":"The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert\u2019s syndrome","volume":"333","author":"Bosma","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.107.017806_bib3","doi-asserted-by":"crossref","first-page":"17960","DOI":"10.1016\/S0021-9258(17)32403-1","article-title":"Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man","volume":"269","author":"Bosma","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.107.017806_bib4","doi-asserted-by":"crossref","first-page":"37547","DOI":"10.1074\/jbc.M506683200","article-title":"Tissue-specific, inducible, and hormonal control of the human UDP-glucuronosyltransferase-1 (UGT1) locus","volume":"280","author":"Chen","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.107.017806_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0076-6879(05)00007-8","article-title":"Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases","volume":"400","author":"Court","year":"2005","journal-title":"Methods Enzymol"},{"key":"10.1124\/dmd.107.017806_bib6","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0022-3565(24)29222-3","article-title":"Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms","volume":"299","author":"Court","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.107.017806_bib7","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1124\/dmd.31.9.1125","article-title":"Evaluation of 3\u2032-azido-3\u2032-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism","volume":"31","author":"Court","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.017806_bib8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0026-895X(25)13456-1","article-title":"Human bilirubin UDP-glucuronosyltransferase catalyzes the glucuronidation of ethinylestradiol","volume":"43","author":"Ebner","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.107.017806_bib9","first-page":"48","article-title":"Use of cloned and expressed human UDP-glucuronosyltransferases for the assessment of human drug conjugation and identification of potential drug interactions","volume":"29","author":"Ethell","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.017806_bib10","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00008571-200011000-00007","article-title":"Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase Activity: relationship between UGT1A1 promotor genotype and variability in a liver bank","volume":"10","author":"Fisher","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.107.017806_bib11","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1124\/dmd.107.016402","article-title":"Interactions between human UGT1A1, UGT1A4, and UGT1A6 affect their enzymatic activities","volume":"35","author":"Fujiwara","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.017806_bib12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1124\/dmd.106.014191","article-title":"Effects of coexpression of UGT1A9 on enzymatic activities of human UGT1A isoforms","volume":"35","author":"Fujiwara","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.017806_bib13","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1124\/mol.62.3.608","article-title":"Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38)","volume":"62","author":"Gagn\u00e9","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.107.017806_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0960-0760(99)00088-6","article-title":"Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7","volume":"70","author":"Gall","year":"1999","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1124\/dmd.107.017806_bib15","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1124\/dmd.32.3.340","article-title":"Human PXR variants and their differential effects on the regulation of human UDP-glucuronosyltransferase gene expression","volume":"32","author":"Gardner-Stephen","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.017806_bib16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1124\/dmd.106.012203","article-title":"Isolation of the UDP-glucuronosyltransferase 1A3 and 1A4 proximal promoters and characterization of their dependence on the transcription factor hepatocyte nuclear factor 1alpha","volume":"35","author":"Gardner-Stephen","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.017806_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/sj.tpj.6500171","article-title":"Pharmacogenomics of human UDP-glucuronosyltransferase enzymes","volume":"3","author":"Guillemette","year":"2003","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/dmd.107.017806_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/15376520600558333","article-title":"Application of Pharmacogenomics in Clinical Pharmacology","volume":"16","author":"Huang","year":"2006","journal-title":"Toxicol Mech Methods"},{"key":"10.1124\/dmd.107.017806_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.tpj.6500072","article-title":"UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity","volume":"2","author":"Iyer","year":"2002","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/dmd.107.017806_bib20","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0009-9236(99)70078-0","article-title":"Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism","volume":"65","author":"Iyer","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.107.017806_bib21","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1172\/JCI915","article-title":"Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes","volume":"101","author":"Iyer","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1124\/dmd.107.017806_bib22","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/0091270003252244","article-title":"Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: report of the first FDA-PWG-PhRMA-DruSafe Workshop","volume":"43","author":"Lesko","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.107.017806_bib23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0300-483X(02)00449-3","article-title":"Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance","volume":"181\u2013182","author":"Miners","year":"2002","journal-title":"Toxicology"},{"key":"10.1124\/dmd.107.017806_bib24","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1021\/tx050317i","article-title":"Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity","volume":"19","author":"Mutlib","year":"2006","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.107.017806_bib25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/03602530600739835","article-title":"Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan","volume":"38","author":"Nagar","year":"2006","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.107.017806_bib26","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/sj.onc.1209375","article-title":"Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer","volume":"25","author":"Nagar","year":"2006","journal-title":"Oncogene"},{"key":"10.1124\/dmd.107.017806_bib27","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1200\/JCO.2006.07.3031","article-title":"Uridine diphosphate glucuronosyltransferase (UGT) 1A1 and irinotecan: practical pharmacogenomics arrives in cancer therapy","volume":"24","author":"O\u2019Dwyer","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1124\/dmd.107.017806_bib28","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2125.2007.02923.x","article-title":"Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes","volume":"64","author":"Peterkin","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.107.017806_bib29","article-title":"Hepatocyte nuclear factor-1 alpha is associated with UGT1A1, UGT1A9 and UGT2B7 mRNA expression in human liver","author":"Ramirez","year":"2007","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/dmd.107.017806_bib30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/bj3030233","article-title":"Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation","volume":"303","author":"Senafi","year":"1994","journal-title":"Biochem J"},{"key":"10.1124\/dmd.107.017806_bib31","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1124\/dmd.31.6.762","article-title":"The effect of incubation conditions on the enzyme kinetics of UDP-glucuronosyltransferases","volume":"31","author":"Soars","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.017806_bib32","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0076-6879(05)00006-6","article-title":"Regulation of the human UGT1A1 gene by nuclear receptors constitutive active\/androstane receptor, pregnane X receptor, and glucocorticoid receptor","volume":"400","author":"Sugatani","year":"2005","journal-title":"Methods Enzymol"},{"key":"10.1124\/dmd.107.017806_bib33","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1124\/dmd.104.003491","article-title":"Differential rates of glucuronidation for 7-ethyl-10-hydroxy-camptothecin (SN-38) lactone and carboxylate in human and rat microsomes and recombinant UDP-glucuronosyltransferase isoforms","volume":"33","author":"Tallman","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.017806_bib34","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1124\/mol.62.3.446","article-title":"Pharmacogenomics of human UDP-glucuronosyltransferases and irinotecan toxicity","volume":"62","author":"Tukey","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.107.017806_bib35","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/hep.21259","article-title":"The liver X-receptor alpha controls hepatic expression of the human bile acid-glucuronidating UGT1A3 enzyme in human cells and transgenic mice","volume":"44","author":"Verreault","year":"2006","journal-title":"Hepatology"},{"key":"10.1124\/dmd.107.017806_bib36","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1124\/dmd.30.11.1266","article-title":"Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes","volume":"30","author":"Williams","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.017806_bib37","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1124\/dmd.105.005447","article-title":"In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation","volume":"33","author":"Zhang","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.017806_bib38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1124\/dmd.106.011932","article-title":"Involvement of multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes in the in vitro metabolism of muraglitazar","volume":"35","author":"Zhang","year":"2007","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624015198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624015198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.107.017806","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T11:14:45Z","timestamp":1739877285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624015198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0090955624015198"],"URL":"https:\/\/doi.org\/10.1124\/dmd.107.017806","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of the UDP Glucuronosyltransferase Activity of Human Liver Microsomes Genotyped for the UGT1A1*28 Polymorphism","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.107.017806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}